Enhancing SUV Accuracy of PET/MR for Clinical Trial Qualification

CompletedOBSERVATIONAL
Enrollment

37

Participants

Timeline

Start Date

June 17, 2019

Primary Completion Date

April 7, 2021

Study Completion Date

April 7, 2021

Conditions
Positron Emission Tomography-Magnetic Resonance (PET-MR)
Interventions
DIAGNOSTIC_TEST

Positron Emission Test / Magnetic Resonance (PET/MR)

The Philips Ingenuity PET/MR is used for research scanning. Patients receiving a clinically indicated PET/CT, will be approached to be included in this study. There is no special preparation other than that needed for the prerequisite PET/CT scanning. At the completion of the PET/CT scanning, the subject will be taken to the PET/MR scanner, which is in close in proximity, for research scanning. The research scanning would take up to one hour or as tolerated.

DIAGNOSTIC_TEST

Positron Emission Test / Computed Tomography (PET/CT)

Patients will receive PET / CT imaging for the detection of cancer or other clinically indicated anomalies. The completed study visit is expected to take approximately 2 hours and not longer than 3 hours.

Trial Locations (1)

44106

University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Case Comprehensive Cancer Center

OTHER

NCT03603925 - Enhancing SUV Accuracy of PET/MR for Clinical Trial Qualification | Biotech Hunter | Biotech Hunter